|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Aug―07 |
Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot study |
Adin Sejdic, Hans Jakob Hartling, Jon G. Holler, Lars Klingen Gjærde, Arnold Matovu Dungu, Maria Elizabeth Engel Møller, Rebecca Svanberg Teglgaard, Carsten Utoft Niemann, Patrick Terrence Brooks, Trine H. Mogensen, Nina Weis, Daria Podlekareva, Marie Louise Baum Jørgensen, Anne Ortved Gang, Ditte Stampe Hersby, Annemette Hald, Susanne Dam Nielsen, Anne-Mette Lebech, Marie Helleberg, Jens Lundgren, Kristina Træholt Franck, Thea K. Fischer, Zitta Barrella Harboe, Hanne Vibeke Marquart, Sisse Rye Ostrowski, Birgitte Lindegaard |
2 |
[GO] |
2024―Jul―26 |
Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19 |
Yihan Wang, Qiu Wang, Furong He, Nan Qiao, Xuejun Li, Liqun Wei, Lingjin Sun, Weiqian Dai, Ying Li, Xueyang Pang, Jiayi Hu, Chuan Huang, Guangchen Yang, Chongjie Pang, Zhidong Hu, Man Xing, Chunxiao Wan, Dongming Zhou |
3 |
[GO] |
2024―Jul―17 |
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa |
Mieke A. van der Mescht, Zelda de Beer, Helen C. Steel, Ronald Anderson, Andries Masenge, Penny L. Moore, Paul Bastard, Jean-Laurent Casanova, Fareed Abdullah, Veronica Ueckermann, Theresa M. Rossouw |
4 |
[GO] |
2024―May―31 |
Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID |
Pedro Martínez-Fleta, María Celeste Marcos, Daniel Jimenez-Carretero, José María Galván-Román, Rosa María Girón-Moreno, Ana Adela Calero-García, Ana Arcos-García, Enrique Martín-Gayo, Hortensia de la Fuente, Laura Esparcia-Pinedo, Javier Aspa, Julio Ancochea, Arantzazu Alfranca, Francisco Sánchez-Madrid |
5 |
[GO] |
2024―May―01 |
Complement system is overactivated in patients with IgA nephropathy after COVID-19 |
Wei-yi Guo, Guo-qin Wang, Ling-qiang Kong, Li-jun Sun, Xiao-yi Xu, Wen-rong Cheng, Hong-rui Dong, Hong Cheng |
6 |
[GO] |
2024―Apr―23 |
135 Integrative characterization of the neuroimmunological interactions of Major Depressive Disorder and its intersection with COVID-19 |
Anny Adri, Dennyson Fonseca, Igor Filgueiras, Fernando Vale, Pedro Barcelos, Kamilla Souza, Adriel Nobile, Julia Usuda, Yohan Lucas Lucas, Helder Nakaya, Gustavo Miranda, Lena Marques, Otávio Marques |
7 |
[GO] |
2024―Apr―23 |
141 Comprehensive characterization of innate and adaptive immune profile of COVID-19 early convalescent children |
Patricia Palmeira, Vera Bain, Heloísa Helena Souza Marques, Simone Corrêa-Silva, Isabela Avelar, Yingying Zheng, Guilherme de Souza Gonçalves, Arthur Eduardo Fernandes Ferreira, Juliana COA Ferreira, Maria Fernanda Badue Pereira, Clóvis Artur Almeida Silva, Magda Carneiro-Sampaio |
8 |
[GO] |
2024―Apr―23 |
137 Case of Mitochondrial Encephalomyopathy Secondary to COVID-19 in a Pediatric Case of SIFD Syndrome with a Novel TRNT1 Mutation |
Madeline Schutt, Amer Khojah, Lauren Gunderman, Ameera Bukhari, Aisha Mirza, Aisha Ahmed |
9 |
[GO] |
2024―Apr―23 |
155 SARS-CoV-2 Breakthrough Infection Increases the Adaptive Immune Responses of Vaccinated Immunosuppressed Children |
Sabryna Nantel, Samuel Sassine, Henintsoa Rabezanahary, Freda Qi, Lesley Ward, Louise Wang, Benoîte Bourdin, Karen Colwill, Gary Chao, Margot Barbosa Da Torre, Kate Zinzser, Jennifer Gommerman, Anne-Claude Gingras, Mariana Baz, Caroline Quach, Helene Decaluwe |
10 |
[GO] |
2024―Apr―23 |
8 Impact of plasma collection date on antibodies to SARS-CoV-2 in intravenous immunoglobulin |
Martyn Paddick, Ramesh Pun, Kim Clark |
11 |
[GO] |
2024―Apr―19 |
Cutaneous adverse reactions associated with COVID-19 vaccines: Current evidence and potential immune mechanisms |
Po-Chien Wu, Wan-Chen Lin, Chuang-Wei Wang, Wen-Hung Chung, Chun-Bing Chen |
12 |
[GO] |
2024―Apr―02 |
Integration of metalloproteome and immunoproteome reveals a tight link of iron-related proteins with COVID-19 pathogenesis and immunity |
Ying Zhou, Tianfan Cheng, Kaiming Tang, Hongyan Li, Cuiting Luo, Fu Yu, Fan Xiao, Lijian Jin, Ivan Fan-Ngai Hung, Liwei Lu, Kwok-Yung Yuen, Jasper Fuk-Woo Chan, Shuofeng Yuan, Hongzhe Sun |
13 |
[GO] |
2024―Feb―28 |
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals |
Eugenia Galeota, Valeria Bevilacqua, Andrea Gobbini, Paola Gruarin, Mauro Bombaci, Elisa Pesce, Andrea Favalli, Andrea Lombardi, Francesca Vincenti, Jessica Ongaro, Tanya Fabbris, Serena Curti, Martina Martinovic, Mirco Toccafondi, Mariangela Lorenzo, Angelica Critelli, Francesca Clemente, Mariacristina Crosti, Maria Lucia Sarnicola, Manuele Martinelli, Lucia La Sala, Alejandro Espadas, Lorena Donnici, Maria Orietta Borghi, Tullia De Feo, Raffaele De Francesco, Daniele Prati, Pier Luigi Meroni, Samuele Notarbartolo, Jens Geginat, Andrea Gori, Alessandra Bandera, Sergio Abrignani, Renata Grifantini |
14 |
[GO] |
2024―Jan―11 |
Immune correlates with disease severity in older patients after SARS-CoV-2 BA.2 infection in Hong Kong |
Na Liu, Runhong Zhou, Anthony Raymond Tam, Wing-Ming Chu, Dawei Yang, Haode Huang, Qiaoli Peng, Zhenglong Du, Bohao Chen, Kelvin Kai-Wang To, Zhiwei Chen |
15 |
[GO] |
2024―Jan―11 |
A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants |
Abhishek Chiyyeadu, Girmay Asgedom, Matthias Bruhn, Cheila Rocha, Tom U. Schlegel, Thomas Neumann, Melanie Galla, Philippe Vollmer Barbosa, Markus Hoffmann, Katrin Ehrhardt, Teng-Cheong Ha, Michael Morgan, Clara T. Schoeder, Stefan Pöhlmann, Ulrich Kalinke, Axel Schambach |
16 |
[GO] |
2023―Dec―27 |
Autoimmune and auto-inflammatory adverse events after COVID-19 vaccination in the United States |
Seong-Jang Kim, Taeho Greg Rhee, Sung Ryul Shim |
17 |
[GO] |
2023―Dec―19 |
The spectrum of side effects associated with COVID-19 vaccines in patients with inborn errors of immunity |
Cansu Özdemiral, Nadira Nabiyeva Cevik, Gizem Yavuz, Onuralp Gormez, Ayse Betül Zengin, Saliha Esenboga, Erdem Karabulut, Deniz Cagdas |
18 |
[GO] |
2023―Nov―22 |
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk |
Marc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, Thomas C. Scheier, Alejandro Gomez-Mejia, Chun-Chi Chang, Pedro D. Wendel-Garcia, Philip K. Buehler, Thomas Buettner, Dirk Roggenbuck, Silvio D. Brugger, Katrin B.M. Frauenknecht |
19 |
[GO] |
2023―Nov―10 |
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production |
Emily S. Córneo, Flavio Protasio Veras, Giovanni F. Gomes, Ayda H. Schneider, Bruna Manuella, Cicero J.L.R. Almeida, Camila M. Silva, Ronaldo B. Martins, Sabrina S. Batah, Carla S. Simon, Gabriele da S. Prestes, José Carlos Alves-Filho, Eurico Arruda, Paulo Louzada-Junior, Renê D.R. de Oliveira, Alexandre T. Fabro, Thiago M. Cunha, Fernando Queiroz Cunha, Felipe Dal-Pizzol |
20 |
[GO] |
2023―Oct―16 |
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors |
Katherine A. Drake, Dimitri Talantov, Gary J. Tong, Jack T. Lin, Simon Verheijden, Samuel Katz, Jacqueline M. Leung, Benjamin Yuen, Vinod Krishna, Michelle J. Wu, Alex Sutherland, Sarah A. Short, Pouya Kheradpour, Maxwell Mumbach, Kate M. Franz, Vladimir Trifonov, Molly V. Lucas, James Merson, Charles C. Kim, Chen Chen, Sairam Parthasarathy, Victor F. Tapson, James N. Moy, Christopher R. de Filippi, Ivan O. Rosas, Mujeeb Basit, Mirella Salvatore, Jerry A. Krishnan |
21 |
[GO] |
2023―Oct―11 |
T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity |
Laura Esparcia-Pinedo, Ángel Lancho-Sánchez, Ilya Tsukalov, María I. Pacheco, Pedro Martínez-Fleta, Belén Pérez-Miés, José Palacios-Calvo, Francisco Sánchez-Madrid, Enrique Martín-Gayo, Arantzazu Alfranca |
22 |
[GO] |
2023―Sep―03 |
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children |
Donato Amodio, Giuseppe Rubens Pascucci, Nicola Cotugno, Chiara Rossetti, Emma Concetta Manno, Chiara Pighi, Elena Morrocchi, Annamaria D'Alessandro, Marco Alfonso Perrone, Alessandra Valentini, Alessio Franceschini, Marcello Chinali, Annalisa Deodati, Chiara Azzari, Paolo Rossi, Stefano Cianfarani, Marco Andreani, Ottavia Porzio, Paolo Palma |
23 |
[GO] |
2023―Aug―14 |
Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations |
Chuang-Wei Wang, Ming-Ying Wu, Chun-Bing Chen, Wei-Chen Lin, Jennifer Wu, Chun-Wei Lu, Wei-Ti Chen, Fang-Ying Wang, Rosaline Chung-Yee Hui, Min-Hui Chi, Tsu-Man Chiu, Ya-Ching Chang, Jing Yi Lin, Yang Yu-Wei Lin, Wan-Ting Tsai, Shuen-Iu Hung, Wen-Hung Chung |
24 |
[GO] |
2023―Jul―26 |
Cytolytic CD8+ T cell response to SARS-CoV-2 and non-SARS-CoV-2-related viruses is associated with severe manifestation of COVID-19 |
Kristina Allers, Verena Moos, Jörg Hofmann, Mario Witkowski, Hildrun Haibel, Stefan Angermair, Thomas Schneider |
25 |
[GO] |
2023―Jul―22 |
Behçet's patients' response to COVID-19 vaccination |
Bindi Gokani, Sarah Sacoor, Georgia R. Leisegang, William Ogunkolade, Azimoon Bibi, Sofia Grigoriadou, Corinna Pade, Joseph Gibbons, Amal Senusi, Farida Fortune |
26 |
[GO] |
2023―Jul―13 |
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype |
Silvestri Ylenia, Clemente Francesca, Moschetti Giorgia, Maioli Sara, Carelli Elena, Espadas de Arias Alejandro, Torelli Rosanna, Longhi Elena, De Feo Tullia, Crosti Maria Cristina, Sarnicola Maria Lucia, Salvi Mario, Mantovani Giovanna, Arosio Maura, Bombaci Mauro, Pesce Elisa, Grifantini Renata, Abrignani Sergio, Geginat Jens, Muller Ilaria |
27 |
[GO] |
2023―Jul―05 |
NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19 |
Huiqing Lin, Jiejie Liu, Ning Li, Birong Zhang, Van Dien Nguyen, Peipei Yao, Jiangpeng Feng, Qianyun Liu, Yu Chen, Guang Li, You Zhou, Li Zhou |
28 |
[GO] |
2023―May―30 |
Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era |
Tomohito Sato, Masataka Umeda, Shuntaro Sato, Toru Michitsuji, Toshimasa Shimizu, Tomohiro Koga, Yuki Furuse, Atsushi Kawakami |
29 |
[GO] |
2023―May―23 |
Association of SARS-COV-2 viral RNAemia, IL- 6 gene polymorphism, serum IL-6 and peripheral blood lymphocytes and monocytes with disease severity in COVID-19 patients |
Shirin Tarafder, Nur Mohammad Khan |
30 |
[GO] |
2023―May―23 |
Retrospective Study on Vaccine Responses and Natural Course of COVID-19 Infections in Primary Immunodeficiency |
Tracy Hwangpo, Harry Schroeder |
31 |
[GO] |
2023―May―23 |
COVID-19-Related Encephalitis in a Child with PIK3CD Defect |
David Potts, Melis Yilmaz, Priya Patel, Minh Nguyen, Joseph Dasso, Boglarka Ujhazi, Sumai Gordon, Krisztian Csomos, Monica Hajirawala, Jolan Walter |
32 |
[GO] |
2023―May―23 |
Anti-interferon-alpha autoantibodies in patients with inborn errors of Immunity and rheumatic diseases before and during the COVID-19 pandemic |
Joseph Dasso, Boglarka Ujhazi, Peter Illes, Sumai Gordon, Serena Shaffren, Eugenia Alas, Krisztian Csomos, Ann Marie Szymanski, Jolan Walter |
33 |
[GO] |
2023―May―23 |
Characteristics and Clinical Implications of Anti-IFN-α cytokine antibodies in partial Recombinase Activating Gene Deficiency patients before and during the COVID-19 Pandemic |
Sumai Gordon, Melis Yilmaz, Joseph Dasso, Caterina Cancrini, Karlla Brigatti, Kevin Strauss, Krisztian Csomos, Jolan Walter, Boglarka Ujhazi, Francesco Licciardi |
34 |
[GO] |
2023―May―23 |
A comprehensive knowledgebase of known and predicted human genetic variants associated with COVID-19 susceptibility and severity |
Meltem Ece Kars, David Stein, Cigdem Sevim Bayrak, Peter Stenson, David Cooper, Yuval Itan |
35 |
[GO] |
2023―May―23 |
Fatal COVID-19 in an infant prompted an early diagnosis of ZNFX1 deficiency in a sibling |
Raed Alzyoud, Motasem Alsuweiti |
36 |
[GO] |
2023―May―23 |
Mild COVID-19 clinical course among paediatric patients with primary immunodeficiency |
Marina Sham, Myra Pereira, Linda Vong, Laura Abrego Fuentes, Abdulrahman Al Ghamdi, Ori Scott, Julia Upton, Vy Hong-Diep Kim, Chaim Roifman |
37 |
[GO] |
2023―May―23 |
Mild COVID-19 outcomes in adults with inborn errors of immunity: a single-center experience |
Laura Abrego Fuentes, Marina Sham, Myra Pereira, Linda Vong, Ori Scott, Abdulrahman Al Ghamdi, Chaim Roifman |
38 |
[GO] |
2023―May―23 |
A Case of a Relapsing Remitting Macrophage Activating Syndrome After Covid-19 Vaccine In a Teenager with UNC13D Heterozygous Variant of Uncertain Significance |
Jessica Simpson, Hanadys Ale, Kristina Wiers-Shamir |
39 |
[GO] |
2023―May―23 |
Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants |
Carolina Romero, José María Diez, Rodrigo Gajardo |
40 |
[GO] |
2023―May―23 |
Association Between Severe SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study |
Sadia Shah, Zeying Du, Si Pham, Mohamed Elrefaei |
41 |
[GO] |
2023―May―23 |
Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains |
Alexa Doss, Chieh-Yu Liang, Jennifer Monroy, James Wedner, Christopher Rigell, Hannah Davis-Adams, Lucas Adams, Peggy Kendall, Michael Diamond, Ofer Zimmerman |
42 |
[GO] |
2023―May―23 |
Characterization of Adaptive Immune Responses to SARS-CoV-2 Updated Bivalent Booster |
Brianna Wachter, Kalpana Manthiram, Qin Xu, Lihong Shi, Pamela Schwartzberg, Peter Burbelo, Muhammad Tauseef Rehman, Robin Dewar, Luigi Notarangelo, Ottavia Delmonte |
43 |
[GO] |
2023―May―23 |
Patients with hereditary angioedema and patients with SARS-CoV-2-associated pneumonia - what can be similar? |
Irina Guryanova, Aliaksandr Liubushkin, Viktoria Kazak, Yulia Zharankova, Inessa Doronina, Alexandr Migas, Mikhail Belevtsev |
44 |
[GO] |
2023―May―05 |
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients |
Andrew D. Hoffmann, Sam E. Weinberg, Suchitra Swaminathan, Shuvam Chaudhuri, Hannah Faisal Mubarak, Matthew J. Schipma, Chengsheng Mao, Xinkun Wang, Lamiaa El-Shennawy, Nurmaa K. Dashzeveg, Juncheng Wei, Paul J. Mehl, Laura J. Shihadah, Ching Man Wai, Carolina Ostiguin, Yuzhi Jia, Paolo D'Amico, Neale R. Wang, Yuan Luo, Alexis R. Demonbreun, Michael G. Ison, Huiping Liu, Deyu Fang |
45 |
[GO] |
2023―May―03 |
Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
Matthew K. Wong, Jun T. Liu, Patrick Budylowksi, Feng Yun Yue, Zhijie Li, James M. Rini, James R. Carlyle, Amin Zia, Mario Ostrowski, Alberto Martin |
46 |
[GO] |
2023―Apr―28 |
Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19 |
June-Young Koh, Jae-Hoon Ko, So Yun Lim, Seongman Bae, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Chi Ryang Chung, Sung-Han Kim, Kyong Ran Peck, Jeong Seok Lee |
47 |
[GO] |
2023―Apr―24 |
Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination |
Ching-Fen Shen, Yi-Chen Fu, Tzong-Shiann Ho, Po-Lin Chen, Nan-Yao Lee, Bo-Yang Tsai, Pei-Jane Tsai, Wen-Chien Ko, Ching-Chuan Liu, Chao-Min Cheng, Chi-Chang Shieh |
48 |
[GO] |
2023―Feb―20 |
Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge |
Jiayi Yan, Jieying Wang, Li Ding, Shang Liu, Yaping Zhan, Jiayue Lu, Zhenyuan Li, Leyi Gu, Ping Li, Mingli Zhu, Yuan Gao, XingRong Gong, Haiqun Ban, Hong Cai, Shan Mou |
49 |
[GO] |
2023―Feb―16 |
Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
Marc Scherlinger, Jean Sibilia, George C. Tsokos, Jacques-Eric Gottenberg |
50 |
[GO] |
2023―Jan―28 |
Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination |
Andreas Törnell, Hanna Grauers Wiktorin, Johan Ringlander, Mohammad Arabpour, Staffan Nilsson, Magnus Lindh, Martin Lagging, Kristoffer Hellstrand, Anna Martner |
51 |
[GO] |
2023―Jan―21 |
Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling |
Akrivi Chrysanthopoulou, Christina Antoniadou, Anastasia-Maria Natsi, Efstratios Gavriilidis, Vasileios Papadopoulos, Evangelia Xingi, Stylianos Didaskalou, Dimitrios Mikroulis, Victoria Tsironidou, Konstantinos Kambas, Maria Koffa, Panagiotis Skendros, Konstantinos Ritis |
52 |
[GO] |
2022―Dec―29 |
Early prediction of COVID-19 outcome using artificial intelligence techniques and only five laboratory indices |
Panagiotis G. Asteris, Styliani Kokoris, Eleni Gavriilaki, Markos Z. Tsoukalas, Panagiotis Houpas, Maria Paneta, Andreas Koutzas, Theodoros Argyropoulos, Nizar Faisal Alkayem, Danial J. Armaghani, Abidhan Bardhan, Liborio Cavaleri, Maosen Cao, Iman Mansouri, Ahmed Salih Mohammed, Pijush Samui, Gloria Gerber, Dimitrios T. Boumpas, Argyrios Tsantes, Evangelos Terpos, Meletios A. Dimopoulos |
53 |
[GO] |
2022―Dec―17 |
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 |
Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, John J. Zaunders, José Alquicira-Hernandez, Seyhan Yazar, Stephanie Ruiz-Diaz, Mandeep Singh, Rama Dhenni, Wunna Kyaw, Fiona Tea, Vera Merheb, Fiona X.Z. Lee, Rebecca Burrell, Annaleise Howard-Jones, Archana Koirala, Li Zhou, Aysen Yuksel, Daniel R. Catchpoole, Catherine L. Lai, Tennille L. Vitagliano, Romain Rouet, Daniel Christ, Benjamin Tang, Nicholas P. West, Shane George, John Gerrard, Peter I. Croucher, Anthony D. Kelleher, Christopher G. Goodnow, Jonathan D. Sprent, Joseph E. Powell, Fabienne Brilot, Ralph Nanan, Peter S. Hsu, Elissa K. Deenick, Philip N. Britton, Tri Giang Phan |
54 |
[GO] |
2022―Nov―08 |
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities |
Murad Alahdal, Eyad Elkord |
55 |
[GO] |
2022―Oct―08 |
Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose |
Emily Rose, Daniel Magliulo, Vasileios C. Kyttaris |
56 |
[GO] |
2022―Sep―30 |
Immunological characteristics of severe acute hepatitis of unknown origin in a child post SARS-CoV-2 infection |
Atsushi Morita, Kazuo Imagawa, Kei Asayama, Tsubasa Terakado, Shoko Takahashi, Katsuyuki Yaita, Manabu Tagawa, Daisuke Matsubara, Hidetoshi Takada |
57 |
[GO] |
2022―Sep―29 |
Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID |
Maria P. Yavropoulou, George C. Tsokos, George P. Chrousos, Petros P. Sfikakis |
58 |
[GO] |
2022―Aug―30 |
Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors |
Bi-Nan Lu, Ka-Li Zhu, Xiao-Ming Cui, Lin Yao, Xue-Jun Wang, Guo-Lin Wang, Li-Jun Duan, Aruna Qian, Mai-Juan Ma |
59 |
[GO] |
2022―Aug―30 |
SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children |
Ki Pui Lam, Marcos Chiñas, Amélie M. Julé, Maria Taylor, Marina Ohashi, Mehdi Benamar, Elena Crestani, Mary Beth F. Son, Janet Chou, Catherine Gebhart, Talal Chatila, Jane Newburger, Adrienne Randolph, Maria Gutierrez-Arcelus, Lauren A. Henderson |
60 |
[GO] |
2022―Aug―13 |
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review |
Emily Drzymalla, Ridgely Fisk Green, Martha Knuth, Muin J. Khoury, W. David Dotson, Adi Gundlapalli |
61 |
[GO] |
2022―Aug―06 |
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19 |
Yuan-Yuan Yong, Li Zhang, Yu-Jiao Hu, Jian-Ming Wu, Lu Yan, Yi-Ru Pan, Yong Tang, Lu Yu, Betty Yuen-Kwan Law, Chong-Lin Yu, Jie Zhou, Mao Li, Da-Lian Qin, Xiao-Gang Zhou, An-Guo Wu |
62 |
[GO] |
2022―Aug―06 |
Decrease in CD8+CD45+CCR7+CD62L+ T cells in individuals vaccinated with Sinovac-CoronaVac following COVID-19 infection |
Dâmaris C.S.C. Fonseca, Mirtes C.B. Rocha, Lucca A. Pereira, Leticia P. Botega, Susanne C.P.F. Cutrim, Fabiano V. Silva, Flávio D. Batista, Adriana S. Rêgo, Ângela Falcai, Lídio G. Lima-Neto, Ana Paula S.A. Santos, Rafael C. Carvalho, Eduardo M. Sousa |
63 |
[GO] |
2022―Aug―06 |
Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: An Italian experience |
Maria Infantino, Lorenza Morena, Massimo Antonio Di Pietro, Benedetta Romanin, Barbara Cimolato, Beatrice Anna Luisa Rocca, Silvia Tunnera, Giulia Modi, Marta Tilli, Valentina Grossi, Barbara Lari, Helena Cerutti, Giulia Tesi, Valentina Anrò, Alessandra Cartocci, Maurizio Benucci, Francesca Veneziani, Patrizia Casprini, Mariangela Manfredi |
64 |
[GO] |
2022―Jun―25 |
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19 |
Mirko Scordio, Federica Frasca, Letizia Santinelli, Leonardo Sorrentino, Alessandra Pierangeli, Ombretta Turriziani, Claudio M. Mastroianni, Guido Antonelli, Raphael P. Viscidi, Gabriella d'Ettorre, Carolina Scagnolari |
65 |
[GO] |
2022―May―02 |
SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination |
Edgardo Guzman Rivera, Asha Patnaik, Joann Salvemini, Sanjeev Jain, Katherine Lee, Daniel Lozeau, Qingping Yao |
66 |
[GO] |
2022―Apr―27 |
Myeloid-derived suppressor cells in COVID-19: A review |
Yuliya V. Perfilyeva, Yekaterina O. Ostapchuk, Raikhan Tleulieva, Aykin Kali, Nurshat Abdolla, Vladimir K. Krasnoshtanov, Anastassiya V. Perfilyeva, Nikolai N. Belyaev |
67 |
[GO] |
2022―Apr―26 |
Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update |
Wen Zhang, Chenman Qin, Yunyun Fei, Min Shen, Yangzhong Zhou, Yan Zhang, Xiaofeng Zeng, Shuyang Zhang |
68 |
[GO] |
2022―Apr―18 |
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure |
Efstratios Gavriilidis, Christina Antoniadou, Akrivi Chrysanthopoulou, Maria Ntinopoulou, Andreas Smyrlis, Iliana Fotiadou, Nikoleta Zioga, Dionysios Kogias, Anastasia-Maria Natsi, Christos Pelekoudas, Evangelia Satiridou, Stefania-Aspasia Bakola, Charalampos Papagoras, Ioannis Mitroulis, Paschalis Peichamperis, Dimitrios Mikroulis, Vasileios Papadopoulos, Panagiotis Skendros, Konstantinos Ritis |
69 |
[GO] |
2022―Apr―07 |
Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients |
Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi |
70 |
[GO] |
2022―Apr―05 |
Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico |
Susana Hernández-Doño, Roberto Alejandro Sánchez-González, Ma Guadalupe Trujillo-Vizuet, Fabiola Yeseline Zamudio-Castellanos, Rafael García-Silva, Pedro Bulos-Rodríguez, Carlos A. Vazquez-Guzmán, Ximena Cárdenas-Ramos, Diana de León Rodríguez, Fabiola Elías, Sergio Domínguez-Arevillaga, José Manuel Pérez-Tirado, Olga Lidia Vera-Lastra, Julio Granados, Jesús Sepúlveda-Delgado |
71 |
[GO] |
2022―Mar―29 |
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19 |
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja Piechocka-Trocha, Kristina Lefteri, Michael T. Waring, Katherine R. Premo, Bruce D. Walker, Jonathan Z. Li, Gaurav Gaiha, Xu G. Yu, Mathias Lichterfeld, Robert F. Padera, Shiv Pillai |
72 |
[GO] |
2022―Mar―23 |
Pandemic chilblains: Are they SARS-CoV-2-related or not? |
Axel De Greef, Pierre G. Coulie, Marie Baeck |
73 |
[GO] |
2022―Mar―17 |
Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants |
Divya Gupta, Farhan Ahmed, Dixit Tandel, Haripriya Parthasarathy, Dhiviya Vedagiri, Vishal Sah, B. Krishna Mohan, Rafiq Ahmad Khan, Chiranjeevi Kondiparthi, Prabhudas Savari, Sandesh Jain, Shashikala Reddy, Jerald Mahesh Kumar, Nooruddin Khan, Krishnan Harinivas Harshan |
74 |
[GO] |
2022―Mar―14 |
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response |
Yves Renaudineau, Florence Abravanel, Jacques Izopet, Chloé Bost, Emmanuel Treiner, Nicolas Congy, Antoine Blancher |
75 |
[GO] |
2022―Mar―05 |
Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine |
Matthew K. Wong, Jun T. Liu, Patrick Budylowksi, Feng Yun Yue, Zhijie Li, James M. Rini, James R. Carlyle, Amin Zia, Mario Ostrowski, Alberto Martin |
76 |
[GO] |
2022―Feb―25 |
Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis |
Hristos Karakizlis, Christian Nahrgang, Kevin Strecker, Jiangping Chen, Mostafa Aly, Heiko Slanina, Christian G. Schüttler, Isla Esso, Martin Wolter, Darina Todorova, Sönke Jessen, Andrea Adamik, Claudio Ronco, Werner Seeger, Rolf Weimer, Martina Sester, Horst-Walter Birk, Faeq Husain-Syed |
77 |
[GO] |
2022―Feb―24 |
A global survey in the developmental landscape of possible vaccination strategies for COVID-19 |
Amin Gasmi, Shvetha Srinath, Maryam Dadar, Lyudmila Pivina, Alain Menzel, Asma Gasmi Benahmed, Salvatore Chirumbolo, Geir Bjørklund |
78 |
[GO] |
2022―Feb―24 |
Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response |
Paul S. Kim, Derek E. Dimcheff, Andrew Siler, Richard J. Schildhouse, Stephen W. Chensue |
79 |
[GO] |
2022―Feb―09 |
The FCGR2Ars1801274 polymorphism was associated with the risk of death among COVID-19 patients |
Rocío López-Martínez, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Elías Cuesta-Llavona, Juan Gómez, Marta García-Clemente, Daniel Vázquez-Coto, Victoria Alvarez, Eliecer Coto |
80 |
[GO] |
2022―Jan―25 |
Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy |
Murat Bektaş, Gökhan Özdemir |
81 |
[GO] |
2022―Jan―19 |
Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study |
Mahmoud M. Alseoudy, Mohamed Elgamal, Dalia A. Abdelghany, Asmaa M. Borg, Ahmed El-Mesery, Dina Elzeiny, Maha O. Hammad |
82 |
[GO] |
2021―Dec―29 |
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring |
Antonio Cristiano, Massimo Pieri, Serena Sarubbi, Martina Pelagalli, Graziella Calugi, Flaminia Tomassetti, Sergio Bernardini, Marzia Nuccetelli |
83 |
[GO] |
2021―Dec―18 |
Association of KIR gene polymorphisms with COVID-19 disease |
Ali Hajeer, Dunia Jawdat, Salam Massadeh, Nora Aljawini, Malak S. Abedalthagafi, Yaseen M. Arabi, Manal Alaamery |
84 |
[GO] |
2021―Nov―27 |
Immunogenicity of SARS-CoV2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters |
Daniel Magliulo, Stefanie D. Wade, Vasileios C. Kyttaris |
85 |
[GO] |
2021―Nov―16 |
Role of NRF2 and Sirtuin activators in COVID-19 |
Hasnat Khan, Shivangi Patel, Anuradha Majumdar |
86 |
[GO] |
2021―Nov―09 |
Adult-onset Still's disease following mRNA COVID-19 vaccination |
Amir Sharabi, Shachaf Shiber, Yair Molad |
87 |
[GO] |
2021―Oct―05 |
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors |
Thomas W. Barnes, Johannes Schulte-Pelkum, Laura Steller, Daniel Filchtinski, Robin Jenness, Michelle R. Williams, Christina Kober, Sandro Manni, Thomas Hauser, Aaron Hahn, Uwe Kalina, Toby L. Simon, Patrick Schuetz, Nathan J. Roth |
88 |
[GO] |
2021―Sep―30 |
Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19 |
Jiezhong Chen, Luis Vitetta |
89 |
[GO] |
2021―Sep―24 |
A hitchhiker's guide through the COVID-19 galaxy |
Susanna Felsenstein, Andreas Otto Reiff |
90 |
[GO] |
2021―Sep―24 |
Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey |
Shirley Shapiro Ben David, Na’ama Shamir-Stein, Sharon Baruch Gez, Uri Lerner, Daniella Rahamim-Cohen, Anat Ekka Zohar |
91 |
[GO] |
2021―Sep―22 |
A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults |
Junghee J. Shin, Sangchoon Jeon, Serhan Unlu, Jennefer Par-Young, Min Sun Shin, John K. Kuster, Yuliya Afinogenova, Yumi Kang, Michael Simonov, Gregory Buller, Richard Bucala, Insoo Kang |
92 |
[GO] |
2021―Sep―11 |
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China |
Shengwei Jin, Hui An, Tong Zhou, Ting Li, Chengshui Chen, Binyu Ying, Zhangye Xu, Xiaokun Li, Ming Li |
93 |
[GO] |
2021―Sep―08 |
Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue |
Waleed H. Mahallawi, Talal M. Aljeraisi |
94 |
[GO] |
2021―Aug―31 |
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year |
Giuseppe A. Ramirez, Lorenza M. Argolini, Chiara Bellocchi, Luca Moroni, Emanuel Della-Torre, Nicola Farina, Roberto F. Caporali, Lorenzo Beretta, Maria Gerosa, Enrica P. Bozzolo, Lorenzo Dagna |
95 |
[GO] |
2021―Aug―27 |
Immunomodulation and immunotherapeutics of COVID-19 |
Sourbh Suren Garg, Atulika Sharma, Jeena Gupta |
96 |
[GO] |
2021―Aug―21 |
Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients |
Kavita Mathi, Yael Rosenberg-Hasson, Holden Maecker, Dennis J. Carlo, Ronald B. Moss |
97 |
[GO] |
2021―Aug―13 |
Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility |
Yashini Govender, Sharon Shalekoff, Osman Ebrahim, Ziyaad Waja, Richard E. Chaisson, Neil Martinson, Caroline T. Tiemessen |
98 |
[GO] |
2021―Aug―12 |
COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era |
A. Deya-Martinez, A. García-García, E.A. Gonzalez-Navarro, L. Yiyi, A. Vlagea, I. Jordan, V. Fumadó, C. Fortuny, M. Español, C. Launes, A. Esteve-Solé, M. Juan, M. Pascal, L. Alsina |
99 |
[GO] |
2021―Aug―04 |
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine |
Miguel García-Grimshaw, Anaclara Michel-Chávez, Juan Mauricio Vera-Zertuche, Javier Andrés Galnares-Olalde, Laura E. Hernández-Vanegas, Melissa Figueroa-Cucurachi, Orlando Paredes-Ceballos, Gustavo Reyes-Terán, Guillermo Carbajal-Sandoval, Santa Elizabeth Ceballos-Liceaga, Antonio Arauz, Sergio Iván Valdés-Ferrer |
100 |
[GO] |
2021―Aug―02 |
BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review |
Michael Stack, Keith Sacco, Riccardo Castagnoli, Alicia A. Livinski, Luigi D. Notarangelo, Michail S. Lionakis |
101 |
[GO] |
2021―Jul―31 |
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection |
Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Nidhi Yadav, Alessandro Floridi, Emanuela Floridi |
102 |
[GO] |
2021―Jul―23 |
Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach |
Ananya Das, Sraddhya Roy, Snehasikta Swarnakar, Nabanita Chatterjee |
103 |
[GO] |
2021―Jul―21 |
COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City |
Kaoru Harada, Hsi-en Ho, Charlotte Cunningham-Rundles |
104 |
[GO] |
2021―Jul―10 |
Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19 |
Simin Jamaly, Maria G. Tsokos, Rhea Bhargava, Olga R. Brook, Jonathan L. Hecht, Reza Abdi, Vaishali R. Moulton, Abhigyan Satyam, George C. Tsokos |
105 |
[GO] |
2021―Jun―29 |
Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay |
Beth L. Cobb, Amr H. Sawalha |
106 |
[GO] |
2021―Jun―29 |
Severe COVID-19 pneumonia in Good syndrome with a favorable outcome |
Maria Lourdes Cos Esquius, Inmaculada López Montesinos, Ramón Gimeno Martinez, Jorge Eguía Núñez, M. Araceli Caballero-Rabasco, Blanca Sánchez González, Alicia López García, Leonardo Mellibovsky |
107 |
[GO] |
2021―Jun―18 |
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study |
Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Laura E. Hernández-Vanegas, Isaac Núñez, Noé Hernández-Valdivia, Daniel Amado Carrillo-García, Anaclara Michel-Chávez, Javier Andrés Galnares-Olalde, Guillermo Carbajal-Sandoval, María del Mar Saniger-Alba, Roger A. Carrillo-Mezo, Sergio Fragoso-Saavedra, Alba Espino-Ojeda, Carlos Blaisdell-Vidal, Juan Luis Mosqueda-Gómez, Juan Sierra-Madero, Rogelio Pérez-Padilla, José Luis Alomía-Zegarra, Hugo López-Gatell, José Luis Díaz-Ortega, Gustavo Reyes-Terán, Antonio Arauz, Sergio Iván Valdés-Ferrer |
108 |
[GO] |
2021―Jun―09 |
Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults |
Kirsi Tamminen, Marjo Salminen, Vesna Blazevic |
109 |
[GO] |
2021―Jun―02 |
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
Panagiotis A. Ntouros, Nikolaos I. Vlachogiannis, Maria Pappa, Adrianos Nezos, Clio P. Mavragani, Maria G. Tektonidou, Vassilis L. Souliotis, Petros P. Sfikakis |
110 |
[GO] |
2021―Apr―28 |
IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report |
Raffaele Badolato, Marco Cattalini, Rosaria Scaduto, Sara Roversi, Jessica Galli, Rosalba Monica Ferraro, Manuela Cortesi, Simona Orcesi, Silvia Giliani, Elisa Fazzi |
111 |
[GO] |
2021―Apr―28 |
Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation |
Viktorija Erdeljic Turk |
112 |
[GO] |
2021―Apr―22 |
SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts |
Christopher Thor Freda, Wei Yin, Berhane Ghebrehiwet, David A. Rubenstein |
113 |
[GO] |
2021―Apr―19 |
A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals |
Yvelise Barrios, Andres Franco, Inmaculada Sanchez-Machin, Paloma Poza-Guedes, Ruperto Gonzalez-Perez, Victor Matheu |
114 |
[GO] |
2021―Apr―15 |
Genetic justification of severe COVID-19 using a rigorous algorithm |
Eleni Gavriilaki, Panagiotis G. Asteris, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, Vassiliki Karali, Apostolia Papalexandri, Christos Varelas, Fani Chatzopoulou, Maria Chatzidimitriou, Dimitrios Chatzidimitriou, Anastasia Veleni, Savvas Grigoriadis, Evdoxia Rapti, Diamantis Chloros, Ioannis Kioumis, Evaggelos Kaimakamis, Milly Bitzani, Dimitrios Boumpas, Argyris Tsantes, Damianos Sotiropoulos, Ioanna Sakellari, Ioannis G. Kalantzis, Stefanos T. Parastatidis, Mohammadreza Koopialipoor, Liborio Cavaleri, Danial J. Armaghani, Anastasia Papadopoulou, Robert Alan Brodsky, Styliani Kokoris, Achilles Anagnostopoulos |
115 |
[GO] |
2021―Apr―09 |
The microbiota-mediated dietary and nutritional interventions for COVID-19 |
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Massimiliano Peana, Alain Menzel, Maryam Dadar, Asma Gasmi Benahmed, Geir Bjørklund |
116 |
[GO] |
2021―Apr―07 |
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products |
Ariel Kenig, Yuval Ishay, Fadi Kharouf, Limor Rubin |
117 |
[GO] |
2021―Apr―03 |
Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon |
Karolina Akinosoglou, Ilektra Tzivaki, Markos Marangos |
118 |
[GO] |
2021―Apr―02 |
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
Francesco Perna, Sara Bruzzaniti, Erica Piemonte, Valeria Maddaloni, Lidia Atripaldi, Silvia Sale, Alessandro Sanduzzi, Carmine Nicastro, Nicola Pepe, Maurizio Bifulco, Giuseppe Matarese, Mario Galgani, Luigi Atripaldi |
119 |
[GO] |
2021―Mar―24 |
Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19 |
Abhigyan Satyam, Maria G. Tsokos, Olga R. Brook, Jonathan L. Hecht, Vaishali R. Moulton, George C. Tsokos |
120 |
[GO] |
2021―Mar―07 |
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study |
Meruyert Dauletova, Hafsan Hafsan, Negah Mahhengam, Angelina Olegovna Zekiy, Majid Ahmadi, Homayoon Siahmansouri |
121 |
[GO] |
2021―Feb―25 |
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection |
Nikolaos I. Vlachogiannis, Kleio-Maria Verrou, Konstantinos Stellos, Petros P. Sfikakis, Dimitrios Paraskevis |
122 |
[GO] |
2021―Feb―21 |
Coronavirus-induced autoimmunity |
Valéry Salle |
123 |
[GO] |
2021―Feb―16 |
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort |
Francesca Caccuri, Antonella Bugatti, Antonella Meini, Carlo Bonfanti, Mario Motta, Lucia Savarè, Alberto Arrighini, Maria Pia Bondioni, Vassilios Lougaris, Arnaldo Caruso, Alessandro Plebani |
124 |
[GO] |
2021―Feb―05 |
Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients |
Isaac Núñez, Ángel A. Priego-Ranero, H. Benjamín García-González, Brenda Jiménez-Franco, Rebeca Bonilla-Hernández, Guillermo Domínguez-Cherit, Javier Merayo-Chalico, José C. Crispín, Ana Barrera-Vargas, Sergio Iván Valdés-Ferrer |
125 |
[GO] |
2021―Jan―12 |
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” |
Rossella Talotta |
126 |
[GO] |
2021―Jan―09 |
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency |
Nicolai S.C. van Oers, Natasha W. Hanners, Paul Sue, Victor Aquino, Quan-Zhen Li, John W. Schoggins, Christian A. Wysocki |
127 |
[GO] |
2020―Dec―16 |
Interrelations between COVID-19 and other disorders |
Amin Gasmi, Massimiliano Peana, Lyudmila Pivina, Shvetha Srinath, Asma Gasmi Benahmed, Yuliya Semenova, Alain Menzel, Maryam Dadar, Geir Bjørklund |
128 |
[GO] |
2020―Dec―16 |
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned |
Varvara A. Ryabkova, Leonid P. Churilov, Yehuda Shoenfeld |
129 |
[GO] |
2020―Dec―08 |
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome |
Maria Rosa Pozzi, Manuela Baronio, Maria Bianchi Janetti, Luisa Gazzurelli, Daniele Moratto, Marco Chiarini, Alessandro Plebani, Vassilios Lougaris |
130 |
[GO] |
2020―Dec―07 |
Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children |
Mohammad-Salar Hosseini |
131 |
[GO] |
2020―Nov―28 |
Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study |
Xiao-Hong Jin, Hui-Li Zhou, Ling-Ling Chen, Guan-Fu Wang, Qiu-Yue Han, Jian-Gang Zhang, Xia Zhang, Qiong-Yuan Chen, Yao-Han Ye, Aifen Lin, Wei-Hua Yan |
132 |
[GO] |
2020―Nov―17 |
COVID-19: A review of therapeutic strategies and vaccine candidates |
Vladislav Izda, Matlock A. Jeffries, Amr H. Sawalha |
133 |
[GO] |
2020―Nov―13 |
Major reduction of NKT cells in patients with severe COVID-19 pneumonia |
Maria Antonella Zingaropoli, Valentina Perri, Patrizia Pasculli, Francesco Cogliati Dezza, Parni Nijhawan, Giulia Savelloni, Giuseppe La Torre, Claudia D'Agostino, Fabio Mengoni, Miriam Lichtner, Maria Rosa Ciardi, Claudio Maria Mastroianni |
134 |
[GO] |
2020―Nov―12 |
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort |
Hèctor Corominas, Ivan Castellví, Virginia Pomar, Rosa Antonijoan, Isabel Mur, Laia Matas, Ignasi Gich, Natividad de Benito, Ana Laiz, Diego Castillo, Laura Villamarin, David Filella, Ana Milena Millán, María Ángeles Quijada, Mireia Puig, Jordi Casademont, Pere Domingo |
135 |
[GO] |
2020―Oct―27 |
Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
Isabel Kinney Ferreira de Miranda Santos, Cristina Ribeiro de Barros Cardoso |
136 |
[GO] |
2020―Oct―25 |
Response to “Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19” |
Dimitrios C. Mastellos, John D. Lambris |
137 |
[GO] |
2020―Oct―23 |
Laboratory biomarkers associated with COVID-19 severity and management |
S. Keddie, O. Ziff, M.K.L. Chou, R.L. Taylor, A. Heslegrave, E. Garr, N. Lakdawala, A. Church, D. Ludwig, J. Manson, M. Scully, E. Nastouli, M.D. Chapman, M. Hart, M.P. Lunn |
138 |
[GO] |
2020―Oct―23 |
An enlightening role for cytokine storm in coronavirus infection |
Zhongyi Zhao, Yinhao Wei, Chuanmin Tao |
139 |
[GO] |
2020―Oct―14 |
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients |
Chun Gao, Li Zhu, Cheng Cheng Jin, Yi Xin Tong, Ai Tang Xiao, Sheng Zhang |
140 |
[GO] |
2020―Sep―19 |
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy |
Dimitrios C. Mastellos, Bruno G.P. Pires da Silva, Benedito A.L. Fonseca, Natasha P. Fonseca, Maria Auxiliadora-Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, Akrivi Chrysanthopoulou, Panagiotis Skendros, Konstantinos Ritis, Ilenia Manfra, Simona Iacobelli, Markus Huber-Lang, Bo Nilsson, Despina Yancopoulou, E. Sander Connolly, Cecilia Garlanda, Fabio Ciceri, Antonio M. Risitano, Rodrigo T. Calado, John D. Lambris |
141 |
[GO] |
2020―Sep―10 |
On the genetics and immunopathogenesis of COVID-19 |
Chaim Oscar Jacob |
142 |
[GO] |
2020―Sep―06 |
SARS-CoV-2 infections in children and young people |
Susanna Felsenstein, Christian M. Hedrich |
143 |
[GO] |
2020―Aug―29 |
Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients |
María Caridad Montalvo Villalba, Odalys Valdés Ramirez, Mayra Muné Jiménez, Amely Arencibia Garcia, Javier Martinez Alfonso, Guelsy González Baez, Rosmery Roque Arrieta, Dianelvys Rosell Simón, Delmis Alvárez Gainza, Beatriz Sierra Vazquez, Sonia Resik Aguirre, Maria Guadalupe Guzmán Tirado |
144 |
[GO] |
2020―Aug―15 |
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients |
Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, Ana García-Soidán, Ana de Malet Pintos-Fonseca, Nieves Alonso Alarcón, Roberto Pariente Rodríguez, Amalia Tejeda Velarde, Sergio Serrano Villar, José Luis Castañer Alabau, Israel Nieto Gañán |
145 |
[GO] |
2020―Aug―06 |
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19 |
Jeffrey Laurence, J. Justin Mulvey, Madhav Seshadri, Alexandra Racanelli, Joanna Harp, Edward J. Schenck, Dana Zappetti, Evelyn M. Horn, Cynthia M. Magro |
146 |
[GO] |
2020―Jul―31 |
Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy |
G.P. Chrousos, G.U. Meduri |
147 |
[GO] |
2020―Jul―23 |
Micronutrients as immunomodulatory tools for COVID-19 management |
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Massimiliano Peana, Alain Menzel, Maryam Dadar, Asma Gasmi Benahmed, Geir Bjørklund |
148 |
[GO] |
2020―Jul―22 |
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine |
Homam Ibrahim, Andras Perl, Deane Smith, Tyler Lewis, Zachary Kon, Ronald Goldenberg, Kinan Yarta, Cezar Staniloae, Mathew Williams |
149 |
[GO] |
2020―Jul―13 |
mTORC inhibitor Sirolimus deprograms monocytes in “cytokine storm” in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome |
Claudio Karsulovic, Mercedes Lopez, Fabian Tempio, Julia Guerrero, Annelise Goecke |
150 |
[GO] |
2020―Jul―12 |
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation? |
James R. McIlroy, Benjamin H. Mullish, Simon D. Goldenberg, Gianluca Ianiro, Julian R. Marchesi |
151 |
[GO] |
2020―Jul―11 |
Long-term infection of SARS-CoV-2 changed the body's immune status |
Lan Lin, Shanshan Luo, Renjie Qin, Mengling Yang, Xiaobei Wang, Qianqian Yang, Yang Zhang, Quansheng Wang, Rui Zhu, Heng Fan, Haijun Wang, Yu Hu, Lin Wang, Desheng Hu |
152 |
[GO] |
2020―Jun―27 |
Imatinib for COVID-19: A case report |
Alejandro Morales-Ortega, David Bernal-Bello, Cristina Llarena-Barroso, Begoña Frutos-Pérez, Miguel Ángel Duarte-Millán, Vanessa García de Viedma-García, Ana Isabel Farfán-Sedano, Eduardo Canalejo-Castrillero, José Manuel Ruiz-Giardin, Justo Ruiz-Ruiz, Juan Víctor San Martín-López |
153 |
[GO] |
2020―Jun―23 |
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment |
Swamy Yeleswaram, Paul Smith, Timothy Burn, Maryanne Covington, Ashish Juvekar, Yanlong Li, Peg Squier, Peter Langmuir |
154 |
[GO] |
2020―Jun―20 |
COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential |
Yujie Jiang, Xin Wei, Jingjing Guan, Shuang Qin, Zhongyong Wang, Hong Lu, Jingjing Qian, Lianfeng Wu, Yingxiao Chen, Yanfan Chen, Xiangyang Lin |
155 |
[GO] |
2020―Jun―13 |
Development of child immunity in the context of COVID-19 pandemic |
Małgorzata Kloc, Rafik M. Ghobrial, Ernest Kuchar, Sławomir Lewicki, Jacek Z. Kubiak |
156 |
[GO] |
2020―Jun―12 |
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy |
Ciceri Fabio, Castagna Antonella, Rovere-Querini Patrizia, De Cobelli Francesco, Ruggeri Annalisa, Galli Laura, Conte Caterina, De Lorenzo Rebecca, Poli Andrea, Ambrosio Alberto, Signorelli Carlo, Bossi Eleonora, Fazio Maria, Tresoldi Cristina, Colombo Sergio, Monti Giacomo, Fominskiy Efgeny, Franchini Stefano, Spessot Marzia, Martinenghi Carlo, Carlucci Michele, Beretta Luigi, Scandroglio Anna Maria, Clementi Massimo, Locatelli Massimo, Tresoldi Moreno, Scarpellini Paolo, Martino Gianvito, Bosi Emanuele, Dagna Lorenzo, Lazzarin Adriano, Landoni Giovanni, Zangrillo Alberto |
157 |
[GO] |
2020―Jun―09 |
Antibody-dependent enhancement and COVID-19: Moving toward acquittal |
Eric J. Yager |
158 |
[GO] |
2020―Jun―08 |
A plea for the pathogenic role of immune complexes in severe Covid-19 |
Dominique A. Vuitton, Lucine Vuitton, Estelle Seillès, Pierre Galanaud |
159 |
[GO] |
2020―May―31 |
Treating COVID-19 with colchicine in community healthcare setting |
Emanuel Della-Torre, Fabrizio Della-Torre, Marija Kusanovic PCP, Raffaella Scotti, Giuseppe Alvise-Ramirez, Lorenzo Dagna, Moreno Tresoldi |
160 |
[GO] |
2020―May―29 |
Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients |
J.M. Urra, C.M. Cabrera, L. Porras, I. Ródenas |
161 |
[GO] |
2020―May―29 |
Type 3 hypersensitivity in COVID-19 vasculitis |
Luca Roncati, Giulia Ligabue, Luca Fabbiani, Claudia Malagoli, Graziana Gallo, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti, Antonio Maiorana |
162 |
[GO] |
2020―May―28 |
Racial disparity in Covid-19 mortality rates - A plausible explanation |
Yuval Tal, Avner Adini, Alal Eran, Irit Adini |
163 |
[GO] |
2020―May―24 |
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases |
Aristo Vojdani, Datis Kharrazianb |
164 |
[GO] |
2020―May―21 |
Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19? |
Loukman Omarjee, Olivier Meilhac, Frédérique Perrot, Anne Janin, Guillaume Mahe |
165 |
[GO] |
2020―May―15 |
Supplements for COVID-19: A modifiable environmental risk |
Trevor K. Young, John G. Zampella |
166 |
[GO] |
2020―May―13 |
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19 |
Loukman Omarjee, Anne Janin, Frédérique Perrot, Bruno Laviolle, Olivier Meilhac, Guillaume Mahe |
167 |
[GO] |
2020―May―11 |
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! |
Alan A. Nguyen, Saddiq B. Habiballah, Craig D. Platt, Raif S. Geha, Janet S. Chou, Douglas R. McDonald |
168 |
[GO] |
2020―Apr―29 |
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 |
Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos, Markus Huber-Lang, Simona Piemontese, Andrea Assanelli, Cecilia Garlanda, John D. Lambris, Fabio Ciceri |
169 |
[GO] |
2020―Apr―27 |
COVID-19: Immunology and treatment options |
Susanna Felsenstein, Jenny A. Herbert, Paul S. McNamara, Christian M. Hedrich |
170 |
[GO] |
2020―Apr―24 |
A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection |
J. Gómez-Rial |
171 |
[GO] |
2020―Apr―20 |
COVID-19 pathophysiology: A review |
Koichi Yuki, Miho Fujiogi, Sophia Koutsogiannaki |
172 |
[GO] |
2020―Apr―18 |
On the molecular determinants the SARS-CoV-2 attack |
Darja Kanduc, Yehuda Shoenfeld |
173 |
[GO] |
2020―Apr―10 |
COVID-19 - Considerations for the paediatric rheumatologist |
Christian M. Hedrich |
174 |
[GO] |
2020―Apr―08 |
COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |
Yuanyuan Han, Mao Jiang, Da Xia, Lichao He, Xin Lv, Xiaohua Liao, Jie Meng |
175 |
[GO] |
2020―Apr―08 |
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |
Amr H. Sawalha, Ming Zhao, Patrick Coit, Qianjin Lu |
176 |
[GO] |
2020―Apr―07 |
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
Amin Gasmi, Sadaf Noor, Torsak Tippairote, Maryam Dadar, Alain Menzel, Geir Bjørklund |
177 |
[GO] |
2020―Apr―01 |
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19 |
Jie Ma, Peng Xia, Yangzhong Zhou, Zhengyin Liu, Xiang Zhou, Jinglan Wang, Taisheng Li, Xiaowei Yan, Limeng Chen, Shuyang Zhang, Yan Qin, Xuemei Li |
178 |
[GO] |
2020―Mar―25 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China |
Wen Zhang, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Xuan Zhang, Xiaowei Yan, Xiaofeng Zeng, Shuyang Zhang |